BeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Nasopharyngeal CancerContributed by: Business WireLogoTagsOncologyHealthGeneral HealthResearchSciencePharmaceuticalBiotechnologyBeiGene, Ltd.